Literature DB >> 2616935

A comparison of tests of homogeneity of odds ratios in K 2 x 2 tables.

S R Paul1, A Donner.   

Abstract

We conducted a simulation study to determine the performance of nine procedures for testing the homogeneity of odds ratios in K 2 x 2 contingency tables. We recommend Tarone's approximate score test, based on the Mantel-Haenszel estimator of the common odds ratio, for use in practice. We also recommend a non-iterative statistic developed by Gart and based on the modified Woolf estimator of the common odds ratio for very large samples in balanced or mildly unbalanced designs. We base our recommendation of a statistic on its performance in terms of size and power in comparison with the other statistics considered.

Entities:  

Mesh:

Year:  1989        PMID: 2616935     DOI: 10.1002/sim.4780081205

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  11 in total

1.  Every family: a population approach to reducing behavioral and emotional problems in children making the transition to school.

Authors:  Matthew R Sanders; Alan Ralph; Kate Sofronoff; Paul Gardiner; Rachel Thompson; Sarah Dwyer; Kerry Bidwell
Journal:  J Prim Prev       Date:  2008-05

2.  How reliable are the multiple comparison methods for odds ratio?

Authors:  Ayfer Ezgi Yilmaz
Journal:  J Appl Stat       Date:  2022-07-26       Impact factor: 1.416

3.  Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesity.

Authors:  F Vasseur; N Helbecque; S Lobbens; V Vasseur-Delannoy; C Dina; K Clément; P Boutin; T Kadowaki; P E Scherer; P Froguel
Journal:  Diabetologia       Date:  2005-04-14       Impact factor: 10.122

4.  Comparison of three tests of homogeneity of odds ratios in multicenter trials with unequal sample sizes within and among centers.

Authors:  Zahra Bagheri; Seyyed Mohammad Taghi Ayatollahi; Peyman Jafari
Journal:  BMC Med Res Methodol       Date:  2011-04-26       Impact factor: 4.615

5.  An accurate test for homogeneity of odds ratios based on Cochran's Q-statistic.

Authors:  Elena Kulinskaya; Michael B Dollinger
Journal:  BMC Med Res Methodol       Date:  2015-06-10       Impact factor: 4.615

6.  Long-Term Mortality of 306,868 Patients with Multi-Vessel Coronary Artery Disease: CABG versus PCI.

Authors:  Jimmy T Efird; Wesley T O'Neal; Stephen W Davies; Whitney L Kennedy; Lada N Alger; Jason B O'Neal; T Bruce Ferguson; Alan P Kypson
Journal:  Br J Med Med Res       Date:  2013-10

7.  Gender differences in cancer susceptibility: an inadequately addressed issue.

Authors:  M Tevfik Dorak; Ebru Karpuzoglu
Journal:  Front Genet       Date:  2012-11-28       Impact factor: 4.599

8.  Lack of association between polymorphisms of the IL18R1 and IL18RAP genes and cardiovascular risk: the MORGAM Project.

Authors:  Marie-Lise Grisoni; Carole Proust; Mervi Alanne; Maylis Desuremain; Veikko Salomaa; Kari Kuulasmaa; François Cambien; Viviane Nicaud; Per-Gunnar Wiklund; Jarmo Virtamo; Frank Kee; Laurence Tiret; Alun Evans; David-Alexandre Tregouet
Journal:  BMC Med Genet       Date:  2009-05-27       Impact factor: 2.103

9.  G/T substitution in intron 1 of the UNC13B gene is associated with increased risk of nephropathy in patients with type 1 diabetes.

Authors:  David-Alexandre Trégouet; Per-Henrik Groop; Steven McGinn; Carol Forsblom; Samy Hadjadj; Michel Marre; Hans-Henrik Parving; Lise Tarnow; Ralph Telgmann; Tiphaine Godefroy; Viviane Nicaud; Rachel Rousseau; Maikki Parkkonen; Anna Hoverfält; Ivo Gut; Simon Heath; Fumihiko Matsuda; Roger Cox; Gbenga Kazeem; Martin Farrall; Dominique Gauguier; Stefan-Martin Brand-Herrmann; François Cambien; Mark Lathrop; Nathalie Vionnet
Journal:  Diabetes       Date:  2008-07-15       Impact factor: 9.461

10.  Road lighting density and brightness linked with increased cycling rates after-dark.

Authors:  Jim Uttley; Steve Fotios; Robin Lovelace
Journal:  PLoS One       Date:  2020-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.